Narcolepsy is a chronic sleep disorder characterised by symptoms of excessi
ve daytime sleepiness and cataplexy. The aim of this study was to describe
the health-related quality of life of people with narcolepsy residing in th
e UK. The study comprised a postal survey of 500 members of the UK narcolep
sy patient association, which included amongst other questions the UK Short
Form 36 (SF-36); the Beck Depression Inventory (BDI), and the Ullanlinna N
arcolepsy Scale (UNS). A total of 305 questionnaires were included in the f
inal analysis. The results showed that the subjects had significantly lower
median scores on all eight domains of the SF-36 than normative data, and s
cot-ed particularly poorly for the domains of role physical, energy/vitalit
y, and social functioning. The BDI indicated that 56.9% of subjects had som
e degree of depression. In addition, many individuals described limitations
on their education, home, work and social life caused by their symptoms. T
here was little difference between the groups receiving different types of
medication. This study is the largest of its type in the UK, although the l
imitations of using a sample from a patient association have been recognise
d. The results are consistent with studies of narcolepsy in other countries
in demonstrating the extensive impact of this disorder on health-related q
uality of life.